Masimo [MASI] vs Globus Medical [GMED] Detailed Stock Comparison
Masimo
NASDAQ
Loading...
Globus Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Masimo wins in 3 metrics, Globus Medical wins in 16 metrics, with 0 ties. Globus Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Masimo | Globus Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 129.16 | 21.62 | Globus Medical |
| Price-to-Book Ratio | 7.45 | 1.77 | Globus Medical |
| Debt-to-Equity Ratio | 61.58 | 2.83 | Globus Medical |
| PEG Ratio | 0.60 | 0.04 | Globus Medical |
| EV/EBITDA | 53.69 | 10.21 | Globus Medical |
| Profit Margin (TTM) | -21.32% | 13.58% | Globus Medical |
| Operating Margin (TTM) | 17.12% | 17.33% | Globus Medical |
| EBITDA Margin (TTM) | 17.12% | 17.33% | Globus Medical |
| Return on Equity | -22.37% | 8.62% | Globus Medical |
| Return on Assets (TTM) | 1.84% | 5.82% | Globus Medical |
| Free Cash Flow (TTM) | $145.30M | $405.21M | Globus Medical |
| 1-Year Return | 5.20% | -17.83% | Masimo |
| Price-to-Sales Ratio (TTM) | 3.61 | 2.86 | Globus Medical |
| Enterprise Value | $8.26B | $7.51B | Masimo |
| EV/Revenue Ratio | 3.83 | 2.86 | Globus Medical |
| Gross Profit Margin (TTM) | 62.90% | 66.62% | Globus Medical |
| Revenue per Share (TTM) | $40 | $19 | Masimo |
| Earnings per Share (Diluted) | $-5.15 | $2.61 | Globus Medical |
| Beta (Stock Volatility) | 1.23 | 1.17 | Globus Medical |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Masimo vs Globus Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Masimo | 2.46% | 4.51% | 6.03% | -14.76% | -14.83% | -13.36% |
| Globus Medical | -1.02% | 5.37% | -3.07% | -4.14% | -23.10% | -29.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Masimo | 5.20% | 8.76% | -39.76% | 269.00% | 412.82% | 629.52% |
| Globus Medical | -17.83% | -2.89% | 8.40% | 156.00% | 330.07% | 330.07% |
News Based Sentiment: Masimo vs Globus Medical
Masimo
News based Sentiment: POSITIVE
Masimo made significant strategic moves in September, including the divestiture of Sound United and an expanded partnership with Philips. These actions, coupled with positive clinical data and analyst upgrades, suggest a positive trajectory for the company, despite some mixed signals from insider activity and a recent legal settlement. The focus on core healthcare technologies positions Masimo for future growth.
Globus Medical
News based Sentiment: MIXED
Globus Medical is showing strong financial growth and innovation, but a declining stock price and decreasing ROIC create a mixed investment picture. The positive analyst ratings and strong market position suggest potential, but investors should carefully monitor key performance indicators and market signals.
Performance & Financial Health Analysis: Masimo vs Globus Medical
| Metric | MASI | GMED |
|---|---|---|
| Market Information | ||
| Market Cap | $7.77B | $7.62B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 737,950 | 1,564,580 |
| 90 Day Avg. Volume | 655,770 | 1,180,947 |
| Last Close | $146.05 | $58.06 |
| 52 Week Range | $131.60 - $194.88 | $51.79 - $94.93 |
| % from 52W High | -25.06% | -38.84% |
| All-Time High | $305.21 (Nov 15, 2021) | $94.93 (Jan 27, 2025) |
| % from All-Time High | -52.15% | -38.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.18% |
| Quarterly Earnings Growth | 2.21% | 5.39% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | 0.14% |
| Operating Margin (TTM) | 0.17% | 0.17% |
| Return on Equity (TTM) | -0.22% | 0.09% |
| Debt to Equity (MRQ) | 61.58 | 2.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.20 | $31.81 |
| Cash per Share (MRQ) | $2.75 | $1.70 |
| Operating Cash Flow (TTM) | $176.60M | $669.16M |
| Levered Free Cash Flow (TTM) | $92.86M | $456.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Masimo vs Globus Medical
| Metric | MASI | GMED |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 129.16 | 21.62 |
| Forward P/E | 30.81 | 16.50 |
| PEG Ratio | 0.60 | 0.04 |
| Price to Sales (TTM) | 3.61 | 2.86 |
| Price to Book (MRQ) | 7.45 | 1.77 |
| Market Capitalization | ||
| Market Capitalization | $7.77B | $7.62B |
| Enterprise Value | $8.26B | $7.51B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.83 | 2.86 |
| Enterprise to EBITDA | 53.69 | 10.21 |
| Risk & Other Metrics | ||
| Beta | 1.23 | 1.17 |
| Book Value per Share (MRQ) | $19.20 | $31.81 |
Financial Statements Comparison: Masimo vs Globus Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MASI | GMED |
|---|---|---|
| Revenue/Sales | $372.00M | $598.12M |
| Cost of Goods Sold | $138.00M | $195.40M |
| Gross Profit | $234.00M | $402.72M |
| Research & Development | $33.90M | $33.06M |
| Operating Income (EBIT) | $80.70M | $98.06M |
| EBITDA | $90.70M | $160.92M |
| Pre-Tax Income | $68.40M | $103.67M |
| Income Tax | $21.20M | $28.21M |
| Net Income (Profit) | $-170.70M | $75.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MASI | GMED |
|---|---|---|
| Cash & Equivalents | $130.80M | $461.27M |
| Total Current Assets | $1.18B | $1.71B |
| Total Current Liabilities | $546.50M | $384.70M |
| Long-Term Debt | $657.70M | $81.69M |
| Total Shareholders Equity | $946.40M | $4.09B |
| Retained Earnings | $1.32B | $1.04B |
| Property, Plant & Equipment | $183.60M | $1.06B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MASI | GMED |
|---|---|---|
| Operating Cash Flow | $62.60M | $193.84M |
| Capital Expenditures | $17.00M | $-36.10M |
| Free Cash Flow | $27.00M | $136.20M |
| Debt Repayment | $-78.80M | $-449.99M |
| Common Stock Repurchase | N/A | $-190.45M |
Short Interest & Institutional Ownership Analysis
| Metric | MASI | GMED |
|---|---|---|
| Shares Short | 3.72M | 6.59M |
| Short Ratio | 6.13 | 6.55 |
| Short % of Float | 0.10% | 0.07% |
| Average Daily Volume (10 Day) | 737,950 | 1,564,580 |
| Average Daily Volume (90 Day) | 655,770 | 1,180,947 |
| Shares Outstanding | 53.60M | 137.42M |
| Float Shares | 46.46M | 111.74M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 1.10% | 1.04% |
Dividend Analysis & Yield Comparison: Masimo vs Globus Medical
| Metric | MASI | GMED |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |